Johnny Jimenez
Primary Care · Stockton, CANPI 1659831725
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,875, 5.7 times the $327 reported in 2022. Among primary care clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $116.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$603
- Phathom Pharmaceuticals, Inc.$501
- Incyte Corporation$370
- Teva Pharmaceuticals USA, Inc.$250
- Novo Nordisk$250
- Sanofi-aventis U.S. LLC$247
- plus $3K from 23 others
What the payments were for
- Food & beverage$5,239100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $603 |
| Phathom Pharmaceuticals, Inc. | 4 | $501 |
| Incyte Corporation | 3 | $370 |
| Teva Pharmaceuticals USA, Inc. | 2 | $250 |
| Novo Nordisk | 2 | $250 |
| Sanofi-aventis U.S. LLC | 2 | $247 |
| Abbott | 2 | $216 |
| Corcept Therapeutics | 2 | $200 |
| Bayer | 3 | $161 |
| Ipsen Biopharmaceuticals, Inc | 1 | $146 |
| Biosense Webster, Inc. | 1 | $141 |
| Alnylam Pharmaceuticals Inc. | 1 | $133 |
| Amgen | 1 | $125 |
| Ardelyx, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Boehringer Ingelheim | 1 | $125 |
| Eisai Inc. | 1 | $125 |
| Argenx US, Inc. | 1 | $125 |
| Idorsia Pharmaceuticals US Inc | 1 | $125 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $123 |
| Ironwood Pharmaceuticals, Inc | 1 | $123 |
| QOL Medical, LLC | 1 | $122 |
| Ultragenyx Pharmaceutical Inc. | 1 | $122 |
| Mayne Pharma Commercial LLC | 1 | $122 |
| Abiomed | 1 | $119 |
| Acadia Pharmaceuticals Inc | 1 | $113 |
| Axsome Therapeutics, Inc. | 1 | $101 |
| Scynexis, Inc. | 1 | $77 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,239 in reported general payments places this provider in the 95th percentile of 706 primary care providers in California.
Other primary care in Stockton
- Leslie FletcherTorrance$1.8M
- Hamideh PourzandLos Angeles$103K
- Veronica RamirezSacramento$83K
- Tyson FieldstedBakersfield$65K
- Kathryn CooperSan Diego$31K
- Shalaine Corbillala Mesa$22K
- Paula StoddardHanford$22K
- Ashley LoweSan Diego$19K
- Vanessa LeeLong Beach$16K
- Lynda TranHuntington Beach$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.